Curtis C. Harris
Impact in
- Cancer Research top 0.01%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Carcinogens and Genotoxicity Assessment
- Oncology top 0.01%
- Cancer-related Molecular Pathways
Papers in
-
- DNA Repair Mechanisms 75
- RNA modifications and cancer 44
- Epigenetics and DNA Methylation 42
- Oncology 207
- Cancer-related Molecular Pathways 132
- Co-authors
- Monica Hollstein (8 shared papers)Bert Vogelstein (3 shared papers)S. Perwez Hussain (42 shared papers)David Sidransky (2 shared papers)Ana I. Robles (50 shared papers)Lorne J. Hofseth (27 shared papers)Aaron J. Schetter (37 shared papers)Elise D. Bowman (61 shared papers)
- Journals
- Carcinogenesis (41 papers)Cancer Research (29 papers)International Journal of Cancer (24 papers)Proceedings of the National Academy of Sciences (23 papers)Oncogene (21 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Curtis C. Harris
572 papers receiving 64.8k citations
Curtis C. Harris's Hit Papers
Peers
Comparison fields: 5 of 205
- Cancer Research 24.8k
- Oncology 22.2k
- Molecular Biology 41.1k
- Biotechnology 3.8k
- Pathology and Forensic Medicine 4.9k
Countries citing papers authored by Curtis C. Harris
This map shows the geographic impact of Curtis C. Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curtis C. Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curtis C. Harris more than expected).
Fields of papers citing papers by Curtis C. Harris
This network shows the impact of papers produced by Curtis C. Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curtis C. Harris. The network helps show where Curtis C. Harris may publish in the future.
Co-authors
The 25 scholars most cited alongside Curtis C. Harris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 579 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | p53 Mutations in Human Cancers Hit paper breakdown → | 1991 | 6725 |
| 2 | A microRNA expression signature of human solid tumors defines cancer gene targets Hit paper breakdown → | 2006 | 4730 |
| 3 | Unique microRNA molecular profiles in lung cancer diagnosis and prognosis Hit paper breakdown → | 2006 | 2484 |
| 4 | Mutations in the p53 gene occur in diverse human tumour types Hit paper breakdown → | 1989 | 2370 |
| 5 | Radical causes of cancer Hit paper breakdown → | 2003 | 1337 |
| 6 | MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma Hit paper breakdown → | 2008 | 1307 |
| 7 | Mutational hot spot in the p53 gene in human hepatocellular carcinomas Hit paper breakdown → | 1991 | 1201 |
| 8 | Clinical Implications of the p53 Tumor-Suppressor Gene Hit paper breakdown → | 1993 | 1123 |
| 9 | Genetic variation in microRNA networks: the implications for cancer research Hit paper breakdown → | 2010 | 1058 |
| 10 | The IARC TP53 database: New online mutation analysis and recommendations to users Hit paper breakdown → | 2002 | 980 |
| 11 | Inflammation and cancer: An ancient link with novel potentials Hit paper breakdown → | 2007 | 855 |
| 12 | The chemical biology of nitric oxide: Implications in cellular signaling Hit paper breakdown → | 2008 | 743 |
| 13 | SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity Hit paper breakdown → | 2001 | 578 |
| 14 | GADD45 induction of a G 2 /M cell cycle checkpoint Hit paper breakdown → | 1999 | 538 |
| 15 | Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways Hit paper breakdown → | 2009 | 524 |
| 16 | Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Hit paper breakdown → | 1986 | 495 |
| 17 | Distribution and modulation of the cellular receptor for transforming growth factor-beta. Hit paper breakdown → | 1987 | 488 |
| 18 | Benzo[ a ]pyrene Diol Epoxides as Intermediates in Nucleic Acid Binding in Vitro and in Vivo Hit paper breakdown → | 1976 | 478 |
| 19 | 1995 | 477 | |
| 20 | 2007 | 455 |
About Curtis C. Harris
Curtis C. Harris is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Biotechnology, having authored 579 papers that have together received 66.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (132 papers), Carcinogens and Genotoxicity Assessment (78 papers), DNA Repair Mechanisms (75 papers), MicroRNA in disease regulation (47 papers), RNA modifications and cancer (44 papers), Epigenetics and DNA Methylation (42 papers), Cancer Research and Treatments (42 papers) and Lung Cancer Treatments and Mutations (41 papers). The work is most often cited by research in Cancer Research (24.8k citations), Oncology (22.2k citations), Molecular Biology (41.1k citations), Biotechnology (3.8k citations) and Pathology and Forensic Medicine (4.9k citations). Curtis C. Harris has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Monica Hollstein, Bert Vogelstein, S. Perwez Hussain, David Sidransky, Ana I. Robles, Lorne J. Hofseth, Aaron J. Schetter, Elise D. Bowman, Carlo M. Croce and Xin Wei Wang. Their work appears in journals such as Carcinogenesis, Cancer Research, International Journal of Cancer, Proceedings of the National Academy of Sciences and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.